Intellectual Property India Publishes Patent Application for 'A Process For The Preparation Of 1,3-Dihydro-2h-Benzo[d]imidazol-2-One' Filed by National Institute Of Pharmaceutical Education And Research

MUMBAI, India, Sept. 12 -- Intellectual Property India has published a patent application (202411013356 A) filed by National Institute Of Pharmaceutical Education And Research, Mohali, Punjab, on Feb. 23, 2024, for 'a process for the preparation of 1,3-dihydro-2h-benzo[d]imidazol-2-one.'

Inventor(s) include Manjinder Singh Gill; and Divakar Singh.

The application for the patent was published on Sept. 12, under issue no. 37/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure relates to a process for the preparation of 1,3-dihydro-2H-benzo[d]imidazol-2-one. The process of the present disclosure is one-step, simple, efficient, economical, environment friendly and provides 1,3-dihydro-2H-benzo[d]imidazol-2-one with high yield and high purity. The process of the present disclosure does not involve expensive and toxic reagents."

Disclaimer: Curated by HT Syndication.